Testicular Tumor Profile LIS Code: SP39
Detect potential testicular abnormalities early with our Testicular Tumor Profile. This test measures key tumor markers to assess testicular health and cancer risk.
What's included in this profile
- A tumour marker most associated with liver and certain reproductive cancers
- Also used in pregnancy screening
- Interpreted alongside imaging and clinical findings
- The hormone produced during pregnancy
- Used to confirm and date early pregnancy
- Also used as a tumour marker in some other contexts
- An enzyme found in many tissues including liver, heart and muscle
- Raised levels can indicate tissue damage from various causes
- A general marker, usually interpreted alongside more specific tests
About this profile
Sample Requirements:
Turnaround Time:
5 days
The Testicular Tumor Profile is a specialised blood test designed to help diagnose and monitor testicular tumors. This profile evaluates key tumor markers that are often elevated in the presence of testicular cancer, providing essential information for diagnosis and treatment planning.
What is the Testicular Tumor Profile?
The Testicular Tumor Profile includes:
Human Chorionic Gonadotropin (hCG Intact + Free β-Subunit): A hormone often elevated in testicular tumors.
Lactate Dehydrogenase (LDH): An enzyme that can be increased in various cancers, including testicular cancer.
Alpha-Fetoprotein (AFP): A protein that may be elevated in certain types of testicular tumors.
Indications for testing
This profile is recommended for:
Individuals with symptoms: Such as lumps or swelling in the testicles, persistent pain, or discomfort.
Monitoring known testicular cancer: To assess response to treatment and detect recurrence.
Post-treatment follow-up: For evaluating the effectiveness of treatment and ensuring complete remission.
What can be detected?
The Testicular Tumor Profile helps in:
Diagnosing testicular cancer: By identifying elevated levels of specific tumor markers associated with testicular tumors.
Monitoring disease progression: Assessing changes in marker levels to track the effectiveness of treatment or detect recurrence.
Guiding treatment decisions: Providing valuable information to tailor treatment strategies based on tumor marker levels.
Fasting requirements
Fasting is not required for the Testicular Tumor Profile. You can eat and drink normally before the test. However, following any specific instructions from your healthcare provider is recommended to ensure accurate results.
Key benefits
The Testicular Tumor Profile offers a comprehensive assessment of key tumor markers associated with testicular cancer. By detecting elevated levels of hCG, LDH, and AFP, this profile supports accurate diagnosis, effective monitoring, and personalized treatment planning for testicular tumors, ensuring optimal patient care.
